Astonea Labs Approves Unaudited Financial Results for H1 FY27

Astonea Labs Limited's Board of Directors, in a meeting held on November 14, 2026, approved the Unaudited Standalone and Consolidated Financial Results for the half-year ended September 30, 2026. The company also noted its voluntary adoption of Indian Accounting Standards (Ind AS) from April 1, 2026. Additionally, the Board approved proposed related party transactions with Longevity Science Private Limited, not exceeding ₹12,00,00,000 (₹12 Crore) for FY 2026-27. Astonea Labs also intends to subscribe to 51% of Longevity Science's share capital, making it a subsidiary, subject to regulatory approvals.